Main Menu
About
Overview
Amgen History
Mission and Values
Leadership
Awards and Accolades
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Pipeline
Scientific Advisory Boards
Amgen Science
Amgen Competitive Grants
Biosimilars
Clinical Trials
Overview
About Clinical Trails
Amgen Clinical Trails
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies
Scientific Community Initiatives
Overview
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Overview
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Overview
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2019 Responsibility Highlights Report
Corporate Responsibility
Strategy & Governance
Overview
Amgen’s Commitment to Patients
Our Approach to Pricing,
Access and Affordability
Access Approaches, Treatments, and Collaborations
Transformative Treatments, Approaches, and Technology
Shaping the Future of Healthcare
Access to Medicine
U.S. Reimbursement Support Services and Financial Assistance Programs
Access to Medicines Initiatives Outside the U.S.
Access to Investigational Medicines
Amgen Foundation
Overview
About the Amgen Foundation
Amgen Foundation Grants
Programs for Teachers
Programs for Students
About the Amgen Foundation
Commitment to Community
Overview
Staff Engagement Programs
Independent Medical Education Funding
U.S. Healthcare Donations
Non-Healthcare Donations and Sponsorships
Equipment Donations
Donation and Grant Recipients
Diversity, Inclusion and Belonging
Amgen's Commitment to Diversity, Inclusion and Belonging
Environment
Overview
Performance
2027 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Supplier Diversity
Supplier Sustainability
Workplace
Safety
Wellness
Reporting and Metrics
Overview
Archived Reports
Summary of Data
CDP
Stakeholder Engagement
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
Amgen Worldwide
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
About
Overview
Amgen History
Mission and Values
Leadership
Awards and Accolades
How We Operate
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Pipeline
Scientific Advisory Boards
Amgen Science
Amgen Competitive Grants
Biosimilars
Clinical Trials
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support Program
Investigator Sponsored Studies
Scientific Community Initiatives
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2019 Responsibility Highlights Report
Corporate Responsibility Strategy & Governance
Amgen's Commitment to Patients
Our Approach to Pricing, Access and Affordability
Access Approaches, Treatments, and Collaborations
Transformative Treatments, Approaches and Technology
Shaping the Future of Healthcare
Access to Medicine
U.S. Reimbursement Support Services and Financial Assistance Programs
Access to Medicines Initiatives Outside the U.S.
Access to Investigational Medicines
Amgen Foundation
Amgen Inspires
About the Amgen Foundation
Programs for Teachers
Programs for Students
Amgen Foundation Grants
Commitment to Community
Staff Engagement Programs
Independent Medical Education Funding
U.S. Healthcare Donations
Non-Healthcare Donations and Sponsorships
Equipment Donations
Donation and Grant Recipients List
Diversity, Inclusion & Belonging
Amgen's Commitment to Diversity, Inclusion and Belonging
Environment
Performance
2027 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Supplier Diversity
Supplier Sustainability
Workplace
Safety
Wellness
Reporting and Metrics
Summary of Data
CDP
Stakeholder Engagement
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
X
Home
>
Stories
>
All Stories
RESPONSIBILITY
11.24.2020
How Some Black Women Experience Cancer, COVID and the Healthcare System
A Q&A with Maimah Karmo, CEO of the Tigerlily Foundation, and global advocate for young Black women with breast cancer.
Read more
All Stories
All
PATIENTS
RESPONSIBILITY
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
All
PATIENTS
RESPONSIBILITY
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
RESPONSIBILITY
04.20.2021
Improving Global Access to Medicine for Pediatric Cancer Patients
PATIENTS
04.15.2021
Connect, Hope and Fight Together: Terri's Story
RESPONSIBILITY
04.14.2021
Amgen Stands With PhRMA to Increase Diversity in Clinical Trials
LEADERSHIP
04.12.2021
Members of Amgen’s Senior Leadership Receive Their
COVID-19
Vaccines
SCIENCE & INNOVATION
04.12.2021
Driver Mutations Explained
SCIENCE & INNOVATION
04.09.2021
Discussing the Pivotal Role Biomarker Testing Plays in Treatment of Lung Cancer Patients
RESPONSIBILITY
04.07.2021
Tackling Adversity Through Diversity
RESPONSIBILITY
04.05.2021
Congratulations to Amgen’s 2020 Environmental Champions
RESPONSIBILITY
04.01.2021
Widespread COVID-19 Vaccination Underway for Amgen Staff in Puerto Rico
SCIENCE & INNOVATION
03.31.2021
Gloves on Gloves? Frocks on Frocks? That’s Biotech Manufacturing, With COVID-19 Add-Ons
PATIENTS
03.30.2021
New Patient Telemedicine Checklist
PATIENTS
03.25.2021
Celebrating Over One Million Cancer Patients Who Have Received Neulasta
®
(pegfilgrastim) Onpro
®
RESPONSIBILITY
03.22.2021
Standing With Our Asian American and Pacific Islander Staff
LEADERSHIP
03.18.2021
Mentoring Women: Amgen's Commitment to Developing Diverse Leaders
LEADERSHIP
03.18.2021
Amgen CEO Bob Bradway's 2020 Letter To Shareholders
LEADERSHIP
03.15.2021
Amgen CEO Bob Bradway Discusses the Future of Biotechnology with Bloomberg News
LEADERSHIP
03.11.2021
“You Are That Strength.” CEO Bob Bradway Reflects on a Year of COVID-19 in Letter to Amgen Employees
RESPONSIBILITY
03.03.2021
Amgen Ranks as One of Barron’s 100 Most Sustainable Companies
RESPONSIBILITY
03.02.2021
Candid Conversations: Women Empowered to be Exceptional (WE2)
PEOPLE & CULTURE
02.26.2021
No Water, No Power and Freezing Temperatures for Some Texas Employees
Load more
Loading...